VSOGF
Vista Energy, S.A.B. de C.V.
$75.00
0.00%
No data for this timeframe.
Vol
SEC Reports3
Recent Activity
Jun 10, 2026
SEC
Vista Energy filed a Form 6-K providing advance notice of its Q2 2026 earnings release scheduled for July 16, 2026, afte
6-K — Impact 3/10
May 11, 2026
SEC
Vista Energy updated its 2026-2028 guidance and 2030 vision, reflecting the consolidation of recently acquired Bandurria
6-K — Impact 4/10
Apr 1, 2026
SEC
Vista Energy, S.A.B. de C.V. announced the pricing of $500 million in aggregate principal amount of 7.875% senior notes
6-K — Impact 5/10
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
6-K
3/10
Vista Energy filed a Form 6-K providing advance notice of its Q2 2026 earnings release scheduled for July 16, 2026, afte
Jun 10, 2026
NEUTRAL
6-K
4/10
Vista Energy updated its 2026-2028 guidance and 2030 vision, reflecting the consolidation of recently acquired Bandurria
May 11, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
3 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 4.0/10.
NEUTRAL
6-K
3/10
Vista Energy filed a Form 6-K providing advance notice of its Q2 2026 earnings release scheduled for
Jun 10, 2026
NEUTRAL
6-K
4/10
Vista Energy updated its 2026-2028 guidance and 2030 vision, reflecting the consolidation of recentl
May 11, 2026
NEUTRAL
6-K
5/10
Vista Energy, S.A.B. de C.V. announced the pricing of $500 million in aggregate principal amount of
Apr 1, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $1.2B | 95.6% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $1.2B | 76.7% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $4.4B | 78.6% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $4.6B | 4.5% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| May 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jan 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.